Filed: 8/14/2024ACC: 0001012975-24-000329
📋 What this filing means
PERCEPTIVE ADVISORS LLC filed this quarterly 13F‑HR report disclosing 110 equity positions with a total reported market value of $4.20B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
110
Positions
$4.20B
Total AUM (reported)
293.76M
Total Shares
Allocation by class
COM$3.45B82.1%
COMMON STOCK$245.77M5.9%
COM NEW$185.96M4.4%
SHS$166.72M4.0%
SPONSORED ADS$86.43M2.1%
CL A$31.24M0.7%
COM PAR $.01$12.06M0.3%
Portfolio Concentration
Top 3$934.41M22.3%
4–10$1.03B24.4%
11–25$975.85M23.2%
Rest$1.26B30.1%
Top 3 weight
22.3%
Top 10 weight
46.7%
Voting Authority Distribution
Total shares with voting rights: 293.76M
Sole
Full voting authority
293.76M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole110
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings110
Rows:
CEREVEL THERAPEUTICS HLDNG I
SOLEShares10.79M
TypeSH
Market value$441.40M
10.51%
Sole
10.79M
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares28.06M
TypeSH
Market value$278.33M
6.63%
Sole
28.06M
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares3.89M
TypeSH
Market value$214.67M
5.11%
Sole
3.89M
Shared
0.00
None
0.00
IOVANCE BIOTHERAPEUTICS INC
SOLEShares25.93M
TypeSH
Market value$207.98M
4.95%
Sole
25.93M
Shared
0.00
None
0.00
NUVALENT INC
SOLEShares2.55M
TypeSH
Market value$193.37M
4.60%
Sole
2.55M
Shared
0.00
None
0.00
RHYTHM PHARMACEUTICALS INC
SOLEShares3.45M
TypeSH
Market value$141.52M
3.37%
Sole
3.45M
Shared
0.00
None
0.00
VAXCYTE INC
SOLEShares1.86M
TypeSH
Market value$140.65M
3.35%
Sole
1.86M
Shared
0.00
None
0.00
SOLENO THERAPEUTICS INC
SOLEShares3.20M
TypeSH
Market value$130.76M
3.11%
Sole
3.20M
Shared
0.00
None
0.00
INTRA-CELLULAR THERAPIES INC
SOLEShares1.72M
TypeSH
Market value$117.56M
2.80%
Sole
1.72M
Shared
0.00
None
0.00
IMMATICS N.V
SOLEShares8.09M
TypeSH
Market value$93.96M
2.24%
Sole
8.09M
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares649.91K
TypeSH
Market value$89.47M
2.13%
Sole
649.91K
Shared
0.00
None
0.00
APOGEE THERAPEUTICS INC
SOLEShares2.11M
TypeSH
Market value$82.86M
1.97%
Sole
2.11M
Shared
0.00
None
0.00
MADRIGAL PHARMACEUTICALS INC
SOLEShares264.60K
TypeSH
Market value$74.13M
1.77%
Sole
264.60K
Shared
0.00
None
0.00
ARTIVION INC
SOLEShares2.79M
TypeSH
Market value$71.66M
1.71%
Sole
2.79M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares3.03M
TypeSH
Market value$71.26M
1.70%
Sole
3.03M
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares1.48M
TypeSH
Market value$66.12M
1.57%
Sole
1.48M
Shared
0.00
None
0.00
EVOLUS INC
SOLEShares5.75M
TypeSH
Market value$62.43M
1.49%
Sole
5.75M
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares1.65M
TypeSH
Market value$62.27M
1.48%
Sole
1.65M
Shared
0.00
None
0.00
CARGO THERAPEUTICS INC
SOLEShares3.68M
TypeSH
Market value$60.47M
1.44%
Sole
3.68M
Shared
0.00
None
0.00
ARCA BIOPHARMA INC
SOLEShares15.51M
TypeSH
Market value$59.39M
1.41%
Sole
15.51M
Shared
0.00
None
0.00
ASTRIA THERAPEUTICS INC
SOLEShares6.49M
TypeSH
Market value$59.02M
1.41%
Sole
6.49M
Shared
0.00
None
0.00
NATERA INC
SOLEShares530K
TypeSH
Market value$57.39M
1.37%
Sole
530K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares2.12M
TypeSH
Market value$56.07M
1.34%
Sole
2.12M
Shared
0.00
None
0.00
VERRICA PHARMACEUTICALS INC
SOLEShares7.10M
TypeSH
Market value$51.75M
1.23%
Sole
7.10M
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares1.49M
TypeSH
Market value$51.55M
1.23%
Sole
1.49M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CEREVEL THERAPEUTICS HLDNG ISOLE | COM | 10.79M | SH | $441.40M 10.51% | 10.79M | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 28.06M | SH | $278.33M 6.63% | 28.06M | 0.00 | 0.00 |
ARCELLX INCSOLE | COMMON STOCK | 3.89M | SH | $214.67M 5.11% | 3.89M | 0.00 | 0.00 |
IOVANCE BIOTHERAPEUTICS INCSOLE | COM | 25.93M | SH | $207.98M 4.95% | 25.93M | 0.00 | 0.00 |
NUVALENT INCSOLE | COM | 2.55M | SH | $193.37M 4.60% | 2.55M | 0.00 | 0.00 |
RHYTHM PHARMACEUTICALS INCSOLE | COM | 3.45M | SH | $141.52M 3.37% | 3.45M | 0.00 | 0.00 |
VAXCYTE INCSOLE | COM | 1.86M | SH | $140.65M 3.35% | 1.86M | 0.00 | 0.00 |
SOLENO THERAPEUTICS INCSOLE | COM | 3.20M | SH | $130.76M 3.11% | 3.20M | 0.00 | 0.00 |
INTRA-CELLULAR THERAPIES INCSOLE | COM | 1.72M | SH | $117.56M 2.80% | 1.72M | 0.00 | 0.00 |
IMMATICS N.VSOLE | SHS | 8.09M | SH | $93.96M 2.24% | 8.09M | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 649.91K | SH | $89.47M 2.13% | 649.91K | 0.00 | 0.00 |
APOGEE THERAPEUTICS INCSOLE | COM | 2.11M | SH | $82.86M 1.97% | 2.11M | 0.00 | 0.00 |
MADRIGAL PHARMACEUTICALS INCSOLE | COM | 264.60K | SH | $74.13M 1.77% | 264.60K | 0.00 | 0.00 |
ARTIVION INCSOLE | COM | 2.79M | SH | $71.66M 1.71% | 2.79M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 3.03M | SH | $71.26M 1.70% | 3.03M | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 1.48M | SH | $66.12M 1.57% | 1.48M | 0.00 | 0.00 |
EVOLUS INCSOLE | COM | 5.75M | SH | $62.43M 1.49% | 5.75M | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 1.65M | SH | $62.27M 1.48% | 1.65M | 0.00 | 0.00 |
CARGO THERAPEUTICS INCSOLE | COM | 3.68M | SH | $60.47M 1.44% | 3.68M | 0.00 | 0.00 |
ARCA BIOPHARMA INCSOLE | COM | 15.51M | SH | $59.39M 1.41% | 15.51M | 0.00 | 0.00 |
ASTRIA THERAPEUTICS INCSOLE | COM | 6.49M | SH | $59.02M 1.41% | 6.49M | 0.00 | 0.00 |
NATERA INCSOLE | COM | 530K | SH | $57.39M 1.37% | 530K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 2.12M | SH | $56.07M 1.34% | 2.12M | 0.00 | 0.00 |
VERRICA PHARMACEUTICALS INCSOLE | COM | 7.10M | SH | $51.75M 1.23% | 7.10M | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 1.49M | SH | $51.55M 1.23% | 1.49M | 0.00 | 0.00 |
Page 1 of 5
…